moxisylyte has been researched along with Endophthalmitis in 1 studies
Moxisylyte: An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)
Endophthalmitis: Suppurative inflammation of the tissues of the internal structures of the eye frequently associated with an infection.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leopold, IH | 1 |
1 review available for moxisylyte and Endophthalmitis
| Article | Year |
|---|---|
The therapeutic tumult and the ophthalmologist. 35th De Schweinitz lecture.
Topics: Adult; Aged; Amino Acids; Animals; Aqueous Humor; Ascorbic Acid; Blood Glucose; Child; Cyclic AMP; D | 1973 |